Physiomics Plc

Leading mathematical modelling company supporting oncology drug development

Physiomics plc is a mathematical modelling company that combines cutting-edge PKPD and QSP modelling techniques with cancer biology expertise, to help biotech and pharma organisations streamline their drug development journeys.

Their approach is to derive insight from all relevant data in order to de-risk decision-making and optimise the design of pre-clinical and clinical studies. Through use of bespoke models and their proprietary Virtual Tumour™ technology, the Physiomics team has informed the development of over 100 projects, over 50 targets and 70 drugs.

Clients include Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics & CRUK. The Company is based in Milton Park, near Oxford and has close ties to the University and Hospital located there.